Kymera Therapeutics (KYMR) PT Raised to $97 at Brookline Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Wall St futures mixed as Apple falls on margin warning, midterm results awaited
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: KYMR) | Delayed: 127.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $127.51 | 52 Week High | $ | |||
| Open | $127.51 | 52 Week Low | $ | |||
| Day High | $127.51 | P/E | N/A | |||
| Day Low | $127.51 | EPS | $ | |||
| Volume | 413 | |||||
